- Home
- ZBRA vs ICLR Comparison
ZBRA vs ICLR Comparison
Compare ZBRA & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZBRA
- ICLR
- Stock Information
- Founded
- ZBRA 1969
- ICLR 1990
- Country
- ZBRA United States
- ICLR Ireland
- Employees
- ZBRA N/A
- ICLR N/A
- Industry
- ZBRA Industrial Machinery/Components
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- Sector
- ZBRA Industrials
- ICLR Health Care
- Exchange
- ZBRA Nasdaq
- ICLR Nasdaq
- Market Cap
- ZBRA 16.2B
- ICLR 13.7B
- IPO Year
- ZBRA 1991
- ICLR 1998
- Fundamental
- Price
- ZBRA $312.65
- ICLR $175.00
- Analyst Decision
- ZBRA Buy
- ICLR Buy
- Analyst Count
- ZBRA 8
- ICLR 15
- Target Price
- ZBRA $351.13
- ICLR $209.93
- AVG Volume (30 Days)
- ZBRA 477.9K
- ICLR 1.0M
- Earning Date
- ZBRA 10-28-2025
- ICLR 10-22-2025
- Dividend Yield
- ZBRA N/A
- ICLR N/A
- EPS Growth
- ZBRA 138.37
- ICLR 13.11
- EPS
- ZBRA 10.59
- ICLR 9.73
- Revenue
- ZBRA $5,190,000,000.00
- ICLR $8,089,820,000.00
- Revenue This Year
- ZBRA $8.47
- ICLR N/A
- Revenue Next Year
- ZBRA $7.33
- ICLR $1.73
- P/E Ratio
- ZBRA $29.52
- ICLR $17.98
- Revenue Growth
- ZBRA 19.12
- ICLR N/A
- 52 Week Low
- ZBRA $205.73
- ICLR $125.10
- 52 Week High
- ZBRA $427.76
- ICLR $310.54
- Technical
- Relative Strength Index (RSI)
- ZBRA 47.71
- ICLR 53.09
- Support Level
- ZBRA $303.48
- ICLR $164.00
- Resistance Level
- ZBRA $316.52
- ICLR $180.95
- Average True Range (ATR)
- ZBRA 6.37
- ICLR 6.38
- MACD
- ZBRA -0.11
- ICLR -0.99
- Stochastic Oscillator
- ZBRA 42.95
- ICLR 64.59
About ZBRA Zebra Technologies Corporation
Zebra Technologies is a leading provider of automatic identification and data capture technology to enterprises. Its solutions include barcode printers and scanners, mobile computers, and workflow optimization software. The firm primarily serves the retail, transportation logistics, manufacturing, and healthcare markets, designing custom solutions to improve efficiency at its customers.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.